Patient and health-care worker perspectives on the short-course regimen for treatment of drug-resistant tuberculosis in Karakalpakstan, Uzbekistan.
Shona HorterJay AcharNell GrayNargiza ParpievaZinaida TigayJatinder SinghBeverley StringerPublished in: PloS one (2020)
The SCR was said to benefit treatment completion and patients' lives. HCW concerns about SCR appropriateness and effectiveness may influence who receives the regimen. These are important considerations for SCR implementation and MDR-TB treatment developments, and dissonance between patient and HCW perspectives must be addressed for successful implementation of shorter regimens in the future.
Keyphrases
- drug resistant
- healthcare
- multidrug resistant
- randomized controlled trial
- systematic review
- end stage renal disease
- mycobacterium tuberculosis
- case report
- emergency department
- chronic kidney disease
- acinetobacter baumannii
- ejection fraction
- quality improvement
- peritoneal dialysis
- cystic fibrosis
- social media
- hepatitis c virus
- human immunodeficiency virus
- health information
- patient reported